Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors

Recent developments in gene engineering technologies have drastically improved the therapeutic treatment options for cancer patients. The use of effective chimeric antigen receptor T (CAR-T) cells and recombinant T cell receptor engineered T (rTCR-T) cells has entered the clinic for treatment of hem...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo Presti, Vania, Buitenwerf, Frank, van Til, Niek P., Nierkens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761868/
https://www.ncbi.nlm.nih.gov/pubmed/33287413
http://dx.doi.org/10.3390/vaccines8040733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761868/
https://www.ncbi.nlm.nih.gov/pubmed/33287413
http://dx.doi.org/10.3390/vaccines8040733

Ejemplares similares